The FDA rejected a new medication to treat opioid addiction that would have been implanted under the skin. The implant, Probuphine, is a long-acting version of buprenophine that is implanted under the skin of the upper arm in a procedure that can be done in a physician’s office in about 10–15 minutes.

You can't view details of this content, please login or buy subscription here